- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04774120
Relationship Between Bispectral Index, EEG Features, and Propofol Effect-site Concentration in Young and Elderly Patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Propofol is an anesthetic drug regularly used in elderly patients requiring anesthesia. The electroencephalographic pattern recognized when propofol is administered is different from the pattern obtained in younger patients. Both groups present alpha and slow delta bands, but younger patients present more intense electroencephalographic bands than older patients (1). The correlation between BIS values and the power of electroencephalographic frequency bands during propofol-remifentanyl anesthesia has not been determined.
The investigators will describe the changes in BIS values and electroencephalographic patterns in young and elderly patients receiving propofol-remifentanyl anesthesia for elective surgery, at different propofol concentration levels. Formal characterization of the dynamic relationship between propofol concentrations at the effect site (Ce), spectral power, and BIS values may provide clinically relevant information to design propofol dose schemes in elderly patients.
The investigators will carry out a prospective observational clinical study at the Clinical Hospital of the Catholic University of Chile. 30 patients, aged 18-85 years, scheduled to undergo elective surgery will be recruited. Standard monitoring and 2 frontal EEG monitors will be installed: Sedline® and BIS®. The electroencephalographic signal from these monitors will be recorded simultaneously from anesthesia induction until extubation. Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) >1% appears in the BIS® EEG monitor. If the SR is not achieved, the infusion rate can be increased by 5 mg/kg/hr every 5 minutes until 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group. When the SR appears, propofol infusion will be stopped. The induction phase will be considered completed at this point. Loss of response (LOR), defined as the timepoint when patients became unresponsive to verbal commands, soft shaking, and eyelash reflex, will be assessed every 30 seconds. When patients become apneic, positive pressure mask ventilation will be started gently at a rate of 10 breaths per minute. After induction of anesthesia, opioids and neuromuscular blocking drugs will be given to facilitate tracheal intubation. When BIS values increase to recommended hypnotic levels for surgery (40-60), the propofol infusion rate will be started again at half of the induction rate. This rate will be adjusted to maintain the alpha band present in the Sedline spectrogram and SEF95 between 8-12 Hz. BIS monitor will be covered and hidden from the attending anesthesiologist during the maintenance phase. After surgery ends, EEG monitoring will continue until the patient's extubation. One hour after extubation, the Brice questionnaire will be performed to detect intraoperative awakening. Propofol concentration will be estimated using the Schnider model.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Metropolitana
-
Santiago, Metropolitana, Chile, 8330024
- Division de Anestesia - Pontificia Universidad Catolica de Chile
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Elderly patients scheduled for surgery are an understudied population. Incidence of postoperative delirium and other complications can be related to changes in cerebral dynamics under anesthesia, with effects observed even after the use of anesthetics agents.
Formal characterization of the dynamic relationship between propofol concentrations at the effect site (Ce), spectral power, and BIS values may provide clinically relevant information to design propofol dose schemes in young and elderly patients.
Description
Inclusion Criteria:
- Adult patients scheduled for elective surgery requiring general anesthesia.
- American Society of Anesthesiology (ASA) Score I or II
Exclusion Criteria:
- Patients with neurological diseases or history of cognitive impairment.
- Requiring the use of two or more drugs affecting Central nervous system
- History of drugs or alcohol abuse
- Body mass index over 35 kg/m^2
- Propofol allergy
- Cardiac congestive failure
- History of coronary syndrome
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Young Patients (Patients aged 18 to 65 years.)
Propofol infusion rate will be started at 20-25 mg/kg/hr until SR achieved.
Then restarted at half of the initial rate.
Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz.
BIS monitor will be covered.
Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
|
Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) is achieved.
If not, can be increased by 5 mg/kg/hr every 5 minutes up to 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group or after 15 minutes have passed.
When the SR appears, propofol infusion will be stopped.
Then restarted at half of the initial rate.
Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz.
BIS monitor will be covered.
Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Other Names:
|
|
Elderly patients (Patients aged 65 to 85 years. )
Propofol infusion rate will be started at 15-20 mg/kg/hr until SR achieved.
Then restarted at half of the initial rate.
Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz.
BIS monitor will be covered.
Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
|
Propofol will be started at a rate of 15-20 mg/kg/hr in patients >65 years and 20-25 mg/kg/hr in younger patients (<65 years) until a suppression rate (SR) is achieved.
If not, can be increased by 5 mg/kg/hr every 5 minutes up to 25 mg/kg/hr in the elderly group and 30 mg/kg/hr in the younger group or after 15 minutes have passed.
When the SR appears, propofol infusion will be stopped.
Then restarted at half of the initial rate.
Maintenance of anesthesia will be guided by Sedline Monitor to maintain an alpha band present in the spectrogram and SEF95 between 8-12 Hz.
BIS monitor will be covered.
Both EEG signals (Sedline and BIS) will be registered simultaneously until the patient's extubation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BIS values at which EEG patterns appears during induction of anesthesia with propofol.
Time Frame: From induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
BIS values correlated to specific EEG patterns (frequency bands, complexity measures and burst suppression)
|
From induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Propofol effect-site concentration (µg/ml) required to observe specific EEG patterns
Time Frame: From induction of anesthesia until loss of consciousness, an average of 15 minutes.
|
Propofol effect-site concentrations achieved at the time that specific EEG patterns appear (frequency bands power, complexity measures and burst suppression).
|
From induction of anesthesia until loss of consciousness, an average of 15 minutes.
|
|
Propofol effect-site concentration (µg/ml) required to achieve loss of consciousness
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
Propofol effect-site concentration (µg/ml) at the moment of loss of consciousness
|
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
|
BIS values at loss of consciousness
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
BIS values at the moment of loss of consciousness
|
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
|
Percentage of time with BIS values between 40-60 and out of this range.
Time Frame: From induction of anesthesia until patient's extubation, an average of 90 minutes.
|
Percentage of time that BIS values are between 40-60 and out of this range.
|
From induction of anesthesia until patient's extubation, an average of 90 minutes.
|
|
Time to achieve loss of consciousness
Time Frame: From Induction of anesthesia until loss of consciousness, an average of 10 minutes.
|
Time (minutes) to achieve loss of consciousness.
|
From Induction of anesthesia until loss of consciousness, an average of 10 minutes.
|
|
Time to achieve loss suppression rate >1% in BIS monitor.
Time Frame: From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
Time (minutes) to achieve loss suppression rate >1% in BIS monitor.
|
From Induction of anesthesia until suppression rate appears, an average of 15 minutes.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daniela Muñoz, MD, Pontificia Universidad Catolica de Chile
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200726002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Florida Institute for Human and Machine CognitionNot yet recruitingAging | Healthy Aging | Aging WellUnited States
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
University of CopenhagenRecruitingAging | Healthy Aging | Aging FrailtyDenmark
-
Radboud University Medical CenterTerminated
-
Northwestern UniversityPotocsnak Human Longevity LabRecruitingAging | Aging Well | Aging, Biological | Aging, HealthyUnited States
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAging | Aging, HealthyFrance
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
Arizona State UniversityActive, not recruiting
-
San Diego State UniversityCompleted
Clinical Trials on Propofol
-
Nurdan SağbaşActive, not recruitingMajor Depression | Bipolar Affective Disorder | Bipolar Depression Depressed PhaseTurkey (Türkiye)
-
Groupe Hospitalier Diaconesses Croix Saint-SimonCompletedOocyte Retrieval | Medically Assisted Procreation (MAP)France
-
Marmara University Pendik Training and Research...Not yet recruitingEndoscopic Submucosal Dissection | Respiratory Complications | Target Controlled Infusion of Propofol | Endoscopy Unit
-
Hacettepe UniversityRecruitingSedation | Target Controlled Infusion of Propofol | Intensive Care Unit SedationTurkey (Türkiye)
-
Hopital FochCompleted
-
Stanford UniversityTiny Blue Dot FoundationEnrolling by invitationHealthy VolunteersUnited States
-
Istanbul University - CerrahpasaRecruitingAtrial Fibrillation | Deep Sedation | Electric CountershockTurkey (Türkiye)
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
Marmara University Pendik Training and Research...RecruitingPediatric Anesthesia | Postoperative Agitations in Pediatric Patients | Postoperative Nausea and Vomiting (PONV) | Emergence Delirium in Pediatric AnesthesiaTurkey (Türkiye)
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands